Fatty Acid Quality and Overweight (FO-study)

June 17, 2015 updated by: Stine Marie Ulven, Oslo Metropolitan University

Fatty Acid Quality and Overweight

The purpose of this study is to study the health effects of fatty acid quality in healthy, overweight individuals.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

41

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Norway
    • Lillestrom
      • Oslo, Lillestrom, Norway, 2001
        • Akershus University College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • no use of medication, healthy, 27<BMI<40

Exclusion Criteria:

  • pregnant and lactating women, chronic diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: Low intake of ALA and triacylglycerols
Sunflower oil
Dietary supplement: fatty acid quality and overweight
Duration 12 weeks
EXPERIMENTAL: high intake of ALA and triacylglyceroles
Canola and linseed oils
Dietary supplement: fatty acid quality and overweight
Duration 12 weeks
EXPERIMENTAL: high intake of ALA and diacylglycerols
Canola and linseed oils
Dietary supplement: fatty acid quality and overweight
Duration 12 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Will intake of fat as diacylglycerols give weight reduction in overweight individuals?
Time Frame: baseline (0 weeks), 12 weeks
baseline (0 weeks), 12 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Will a high intake of ALA involve reduced levels of inflammatory markers?
Time Frame: baseline (0 weeks), 12 weeks
baseline (0 weeks), 12 weeks
Will a high intake of ALA involve changes in insulin sensitivity?
Time Frame: baseline (0 weeks), 12 weeks
baseline (0 weeks), 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Oslo Metropolitan University

Investigators

  • Study Chair: Stine Marie Ulven, PhD, University Hospital, Akershus

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2009

Primary Completion (ACTUAL)

June 1, 2009

Study Registration Dates

First Submitted

December 16, 2009

First Submitted That Met QC Criteria

December 16, 2009

First Posted (ESTIMATE)

December 17, 2009

Study Record Updates

Last Update Posted (ESTIMATE)

June 18, 2015

Last Update Submitted That Met QC Criteria

June 17, 2015

Last Verified

June 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 6.2008.1368

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Weight Reduction and Insulin Sensitivity

Clinical Trials on fatty acid quality and overweight

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe